A Study of JNJ-90189892 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms

Clinical trial NCT06651229 · RECRUITING

Trial details

NCT number: NCT06651229
Sponsor: Janssen Research & Development, LLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute Myelodysplastic Neoplasms

Start date: 2025-03-21
Primary completion: 2027-08-05
Enrollment: 155

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.